LDHA and non-small cell lung carcinoma: The fluoroquinolone levofloxacin and derivatives have shown cytotoxic effects in combination with doxorubicin in the A549 cell line, a non-small cell lung cancer (NSCLC) cell line, in addition to antioxidant effects by inhibiting aldehyde dehydrogenase (ALDH) [27].